BioElectronics Receives Working Capital Infusion

BioElectronics Receives Working Capital Infusion

/* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:"Arial";
color:black;
}
a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:"Arial";
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:"Arial";
color:black;
margin:"0in";
}

BioElectronics Receives Working Capital Infusion

Ex-Im Bank Provides Export Financing Support

PR Newswire

FREDERICK, Md., May 29, 2013

FREDERICK, Md., May 29, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, is pleased to announce it has been issued a $500,000 Line of Credit from Ex-Im Bank to create jobs and assist with export working capital.

The funding will enable BioElectronics to increase production of its existing products and expand export sales worldwide. The Company has established distribution agreements with more than 20 distributors in over 30 countries in Asia, Europe, Canada and Central and South America.

"Our products have been awarded innovation awards from The Wall Street Journal and the prestigious OTC Bulletin drugstore trade journal and we very much appreciate the Ex-Im Bank's loan and international accounts receivable insurance coverage," said Andrew J. Whelan, President, BioElectronics.

About BioElectronics Corporation

BioElectronics (www.bielcorp.com) is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care.

Contact:

Paul Knopick

940.262.3584

pknopick@eandecommunications.com

SOURCE BioElectronics Corporation

Bioelectronics (PK) (USOTC:BIEL)
Historical Stock Chart
From Mar 2024 to Apr 2024